Loading Events

« All Events

#AgileLeaders: Unlocking Challenging Targets with Small Molecules and Beyond

10th November @ 1:30 pm - 5:30 pm

Biosell UK runs the prestigious life science innovation thought-leader forums #AgileLeaders and #CreativeDisruption (in-person), as well as the virtual #coffeebuddies series. These events bring together leading minds in life sciences, business, and research to explore the future of innovation.

This Agile Leaders Forum will explore Lab-in-the-Loop: How AI–Experiment Synergy is Shaping the Future of Drug Discovery — a must-attend session for business and research leaders driving innovation at the intersection of science and technology.

Please note: Attendance is open to senior leaders of innovation-focused companies. The organisers (Biosell UK, not Innovate Cambridge) will conduct a vetting process for participants.

 

Powered by Railpen.

Venue

Open Space
The Glasshouse, Innovate Cambridge, Botanic House, 1st floor
Cambridge, CB21PH United Kingdom
+ Google Map

Glasshouse Closed

From time to time, the Glasshouse will be fully closed to members to host private events. These may be due to space limitations, confidentiality,  or resource constraints. Such events will be clearly marked as Glasshouse Closed.

 

Closed Meeting 

Invite-only meetings or events where attendance is strictly limited to those personally invited. This may include confidential partner meetings or internal planning workshops. These will appear as Closed Meeting.

 

Open to Members 

Events open to all members of the Glasshouse community. They are designed to encourage interaction, collaboration, and the exchange of ideas across sectors. Members are warmly encouraged to attend, connect, share, and grow their networks. These will appear as Open to Members.

 

Open to All 

Events open to the wider innovation ecosystem, including Glasshouse members and friends. These gatherings are an opportunity to connect, exchange ideas, and collaborate across Cambridge and beyond. These will appear on the calendar as Open to All.